OrthoPediatrics Corp Finite-Lived Intangible Asset, Expected Amortization, Year Three
OrthoPediatrics Corp (KIDS) had Finite-Lived Intangible Asset, Expected Amortization, Year Three of $7.16 million as of 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree · last filed 2026-03-04
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Three $7.16M.
- 2024-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Three $7.26M.
- 2023-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Three $7.34M.
- 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year Three $6.06M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year Three |
|---|---|
| 2025-12-31 | $7.16M 10-K · filed 2026-03-04 |
| 2024-12-31 | $7.26M 10-K · filed 2025-03-05 |
| 2023-12-31 | $7.34M 10-K · filed 2024-03-08 |
| 2022-12-31 | $6.06M 10-K · filed 2023-03-01 |
| 2021-12-31 | $5.14M 10-K · filed 2022-03-03 |
| 2020-12-31 | $3.78M 10-K · filed 2021-03-11 |
| 2019-12-31 | $1.15M 10-K · filed 2020-03-05 |
| 2018-12-31 | $302.00K 10-K · filed 2019-03-07 |
| 2017-12-31 | $359.00K 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| CARLSMED, INC. (CARL) | United States | $0.405B |